ÂÜÀòÂÒÂ×

The Research and Development team at GlycoMimetics is dedicated to innovating and advancing therapeutic candidates through rigorous research and scientific exploration. Comprising experts in medicinal chemistry and global medical affairs, the team focuses on discovering novel glycobiology-based treatments aimed at improving outcomes for patients with sickle cell disease, cancer, and other serious illnesses. Their collaborative efforts drive the pipeline of breakthrough therapies, aligning with the company's mission to provide hope and transformative solutions for patients.